Adamas Pharmaceuticals, Inc. was a big mover last session, as the company saw its shares rise above 5% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $15.48 to $18.05 in the past one-month time frame.

In the last 30 days, the company has seen no estimate revision and the Zacks Consensus Estimate also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.       

ADMS currently carries a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Adamas Pharmaceuticals, Inc. Price

 

Adamas Pharmaceuticals, Inc. Price | Adamas Pharmaceuticals, Inc. Quote

A better-ranked Medical-Generic Drugs stock is Versartis, Inc. , which holds a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Zacks' Top Investment Ideas for Long-Term Profit

How would you like to see our best recommendations to help you find today’s most promising long-term stocks? Starting now, you can look inside our portfolios featuring stocks under $10, income stocks, value investments and more. These picks, which have double and triple-digit profit potential, are rarely available to the public. But you can see them now. Click here >>